Antimicrobial susceptibility profile among β-haemolytic Streptococcus spp. collected in the SENTRY Antimicrobial Surveillance Program - North America, 2001

Diagnostic Microbiology and Infectious Disease

Volumn 46, Issue 4, 2003, Pages 291-294

  Biedenbach, Douglas J ^a   Stephen, Jennifer M ^a   Jones, Ronald N ^a,b  

^a JMI LABORATORIES   (United States)

^b TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFEPIME; CEFTRIAXONE; CHLORAMPHENICOL; CLINDAMYCIN; DALFOPRISTIN; ERYTHROMYCIN; GATIFLOXACIN; LEVOFLOXACIN; LINEZOLID; PENICILLIN G; QUINUPRISTIN; TETRACYCLINE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BETA HEMOLYTIC STREPTOCOCCUS; CONTROLLED STUDY; EVALUATION; FEMALE; GENOTYPE; HEALTH CARE SYSTEM; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR DYNAMICS; NONHUMAN; NORTH AMERICA; PATHOGENESIS; PHENOTYPE; RANDOMIZATION;

EID: 0041926266     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(03)00065-8     Document Type: Article

References (18)

1. Andrews J.I., Diekema D.J., Hunter S.K., Rhomberg P.R., Pfaller M.A., Jones R.N., Doern G.V. Group B streptococci causing neonatal blood stream infection Antimicrobial susceptibility and serotyping. Results from the SENTRY centers in the Western Hemisphere . Am J Obst Gyn. 4:2000;859-862.
2. Avanzini C., Bosio K., Volpe G., Dotti G., Savoia D. Streptococcus pyogenes collected in Torino (northwest Italy) between 1983 and 1998 Survey of macrolide resistance and trend of genotype by RAPD . Microbial Drug Resistance. 6:2000;289-295.
3. Bisno A.L., Gerber M.A., Gwaltney J.M., Kaplan E.L., Schwartz R.H. Practice guidelines for the diagnosis and management of group A streptococcal pharyngitis. Clin Infect Dis. 35:2002;113-125.
4. Critchley I.A., Sahm D.F., Thornsberry C., Blosser-Middleton R.S., Jones M.E., Karlowsky J.A. Antimicrobial susceptibilities of Streptococcus pyogenes isolated from respiratory and skin and soft tissue and infections United States LIBRA surveillance data from 1999 . Diagn Microbiol Infect Dis. 42:2001;129-135.
5. De Azavedo J.C., McGavin M., Duncan C., Low D.E., McGeer A. Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B Streptococcus isolates from Ontario, Canada. Antimicrob Agents Chemother. 45:2001;3504-3508.
6. Farrell D.J., Morrisey I., Bakker G., Felmingham D. Detection of macrolide resistance mechanisms in Streptococcus pneumoniae and Streptococcus pyogenes using a multiplex rapid cycle PCR with microwell-format probe hybridization. J Antimicrob Chemother. 48:2001;541-544.
7. Gillespie S.H. Failure of penicillin in Streptococcus pyogenes pharyngeal infection. Lancet. 352:1998;1954-1956.
8. Gordon K.A., Beach M.L., Biedenbach D.J., Jones R.N., Rhomberg P.R., Mutnick A.H. Antimicrobial susceptibility patterns of β-haemolytic and viridans group streptococci Report from the SENTRY Antimicrobial Surveillance Program (1997-2000) . Diagn Microbiol Infect Dis. 43:2002;157-162.
9. Hsueh P.-R., Teng L.-J., Lee L.-N., Ho S.-W., Yang P.-C., Luh K.-T. High incidence of erythromycin resistance among clinical isolates of Streptococcus agalactiae in Taiwan. Antimicrob Agents Chemother. 45:2001;3205-3208.
10. Leclercq R. Mechanisms of resistance to macrolides and lincosamides Nature of the resistance elements and their clinical implications . Clin Infect Dis. 34:2002;482-492.
11. Murdoch D.R., Reller L.B. Antimicrobial susceptibilities of group B streptococci isolated from patients with invasive disease 10 year perspective . Antimicrob Agents Chemother. 45:2001;3623-3624.
12. Nagai K., Appelbaum P.C., Davies T.A., Kelly L.M., Hoellman D.B., Andrasevic A.T., Drukalska L., Hryniewicz W., Jacobs M.R., Kolman J., Miciuleviciene J., Pana M., Setchanova L., Thege M.K., Hupkova H., Trupl J., Urbaskova P. Susceptibility to telithromycin in 1,011 Streptococcus pyogenes isoaltes from 10 central and eastern European countries. Antimicrob Agents Chemother. 46:2002;546-549.
13. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically - Fifth Edition Approved standard M7-A6 . 2003;NCCLS, Wayne, PA.
14. Performance standards for antimicrobial susceptibility testing. Supplemental tables, M100-S13. 2003;NCCLS, Wayne, PA.
15. Perez-Trallero E., Fernandez-Mazarrasa C., Garcia-Rey C., Bouza E., Aguilar L., Garcia-de-Lomas J., Baquero F. Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships Results of a 1-year (1998-1999) multicenter surveillance study in Spain . Antimicrob Agents Chemother. 45:2001;3334-3340.
16. Ruoff K.L. Streptococcus. Murray P.R., Baron E.J., Pfaller M.A., Tenover C., Yolken R.H. Manual of clinical microbiology, 7th ed. 1999;283-296 American Society for Microbiology, Washington, DC.
17. Schuchat A. Group B streptococcal disease From trials and tribulations to triumph and trepidation . Clin Infect Dis. 33:2001;751-756.
18. Weiss K., De Azavedo J., Restieri C., Galarneau L.A., Gourdeau M., Harvey P., Paradis J.F., Salim K., Low D.E. Phenotypic and genotypic characterization of macrolide-resistant group a Streptococcus strains in the province of Quebec, Canada. J Antimicrob Chemother. 47:2001;345-348.